Eversense 365 + twiist: New Data & What’s Next for the Implantable CGM

This week on Diabetes Connections.. Now that Eversense 365-day has been out in the real world  and is working with the twiist automated insulin delivery system, we’re starting to get a much better picture of what that combination can actually do. This week, Dr. Fran Kaufman is back with new data on Eversense 365, including…

Type 1 Diabetes Screening Has Changed. What You Need to Know Now (Bonus episode)

A few years ago, when we talked about screening for type 1 diabetes, it still felt a little bit like we were talking about the future. That future may be arriving faster than we realize. Dr. Bryce Nelson is back on the show. After years as a pediatric endocrinologist, he’s now working specifically in autoimmune type…

Inside the new Flex Pump – and what’s coming next from MiniMed with Chief Technology Officer Ali Dianaty

This week on Diabetes Connections, we’re talking about the newest pump from MiniMed – the Flex looks a lot different from any pump produced by the company formerly known as Medtronic Diabetes. It has no screen it’s controlled by phone.. and has a lot of other features we’ll get into. I’m speaking to MiniMed’s EVP,…

Omnipod + Calm: A New Tool for the Mental Load of Type 1 Diabetes

On this bonus episode of Diabetes Connections… we’re talking about a fascinating new partnership between Omnipod and Calm – the meditation app, designed specifically for people with type 1 diabetes. Calm says it helps people sleep more, stress less and live mindful.. what does that look like for our community? I’m talking to advocate Meg…

BONUS Episode: Afrezza Approved for Kids: A Deep Dive Into Inhaled Insulin with INHALE-1 Lead Investigator Dr. Jamie Wood

On this bonus episode of Diabetes Connections.. a deep dive into inhaled insulin for kids. Last week the FDA approved Afrezza for kids six and older – it’s been approved for adults for more than a decade – and boy did you have questions. We’re talking to Dr. Jamie Wood, pediatric endocrinologist and  principal investigator…

Inside Tandem’s Next Chapter: Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup

This week on Diabetes Connections.. an update from Tandem Diabetes. Quite a few approvals and advances have already happened for Tandem this year, as the company looks ahead to the launch of their latest product, the Mobi Tubeless, not yet FDA approved. I’m talking to Marisa Fienup VP of Product Management about how this product…

The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice

In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There’s no other insulin on the market quite like this long-acting – and it turns out the community wasn’t letting it go without a fight. My guests are going to tell you more about why. I’m taking…